HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ulrika Morris Selected Research

Ulrika Morris Research Topics

Disease

12Malaria
01/2022 - 09/2012
6Falciparum Malaria (Plasmodium falciparum Malaria)
01/2022 - 03/2013
4Infections
02/2021 - 10/2013
2Reinfection
02/2021 - 10/2013

Drug/Important Bio-Agent (IBA)

5artemisinin (artemisinine)IBA
01/2022 - 09/2012
4Lumefantrine Drug Combination Artemether (Coartem)FDA Link
06/2020 - 10/2013
2ArtesunateIBA
02/2021 - 01/2020
2Amodiaquine (Camoquin)FDA Link
02/2021 - 01/2020
2DNA (Deoxyribonucleic Acid)IBA
01/2017 - 03/2013
1Antimalarials (Antimalarial Agents)IBA
01/2022
1Cytochrome P-450 CYP2C8IBA
02/2021
1Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
02/2021
1PrimaquineFDA Link
06/2020
1Chloroquine (Aralen)FDA LinkGeneric
06/2020
1LumefantrineFDA Link
06/2020
12- methyl- 3- (4- phenylpiperidino)propionohydroxamic acid hydrochloride (K 76)IBA
06/2020
1Cytochromes b (Cytochrome b)IBA
01/2015
1SYBR Green IIBA
01/2015
1AntigensIBA
10/2013

Therapy/Procedure

5Therapeutics
01/2022 - 09/2012
1Drug Therapy (Chemotherapy)
02/2021
1Mass Drug Administration
12/2018